The University of Notre Dame Forms Partnership with Bruker Corp. To Develop Top Imaging Facility

25 Jul 2013
Sarah Thomas
Associate Editor

Product news

The University of Notre Dame has established a formal partnership with Bruker Corp., a world leader in scientific instrumentation. The partnership will develop one of the Midwest's top imaging facilities at Notre Dame. The arrangement, called Bruker at Notre Dame (BAND), will allow the Notre Dame Integrated Imaging Facility (NDIIF) and Bruker to collaborate on research, training and new application development.

Robert J. Bernhard, Notre Dame's vice president for research, said the agreement will accelerate a wide range of research, education and outreach activities. "The partnership will enable Notre Dame students and faculty to utilize innovative technology from Bruker in our programs, which we believe will also inform Bruker about future markets," he said. "We believe this partnership will be mutually beneficial to both parties and are very pleased to formalize our relationship."

The University already houses several powerful and versatile small animal imaging systems, including Bruker's In-Vivo MS FX PRO and In-Vivo Xtreme 16MP optical/X-ray imaging systems and the Albira PET/SPECT/CT System. The partnership, which will be spearheaded by research assistant professor W. Matthew Leevy, an in vivo imaging expert at NDIIF, will provide more equipment and continued product and research support.

"The field of biomedical imaging is advancing very rapidly, and there is a continual need to upgrade capabilities," said Brad Smith, director of the NDIIF. "Working closely with a major company like Bruker allows students and staff of the Notre Dame Integrated Imaging Facility to keep abreast of the latest technical advances. Likewise, the NDIIF can feed back to Bruker new ideas of unmet imaging needs. Together, we can work toward a common mission of improving biomedical imaging for the research and health service communities."

Links

Tags

Clinical TrialsClinical Trials, an essential part of drug discovery process, assess the safety and effectiveness of a new medication or device in the pharmaceutical industry. Clinical Trials are a phased process (Phase 0, Phase I, Phase II, Phase III and Phase IV) which begins after initial preclinical testing.In Vivo Imaging Systems<i>In vivo</i> imaging systems, including pre-clinical imaging systems and medical imaging systems are used to non-invasively visualize and capture images of live animals and plants. Monitor the natural processes or diseases of your subjects using small-animal pre-clinical imaging systems, including single photon positron emission tomography (SPECT), positron emission tomography (PET), computed tomography (micro-CT), magnetic resonance imaging (MRI), X-ray radiography, ultrasound, fluorescence and bioluminescence imagers. Multimodal systems and software solutions are also available for correlative analysis of organ, tissue, cell, or molecular-level processes. Find the best in vivo imaging products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.ImagingImaging techniques are essential for obtaining visual representations of samples to understand structures, processes, and function in biological, chemical, and physical research. These tools range from traditional light microscopy to advanced imaging modalities like MRI and electron microscopy, providing researchers with valuable data for diagnostics, drug discovery, and material analysis. Explore imaging solutions in our peer-reviewed product directory to compare products, check reviews, and get pricing directly from manufacturers.
The University of Notre Dame Forms Partnership with Bruker Corp. To Develop Top Imaging Facility